Riskpilot← Back to searchSign inGet full accessDr. Acke AB
ABActiveOrg 5590939889Tegnérgatan 45General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2024
SEK 151K
-49% vs 2023
EBITDA margin
9.7%
-75% vs 2023
Equity ratio
27.4%
Financial strength
Net profit 2024
SEK -6K
-116% vs 2023
| Revenue | SEK 151K | -49% |
| EBITDA | SEK 15K | -75% |
| Net profit | SEK -6K | -116% |
| Total assets | SEK 283K | -22% |
| Equity | SEK 78K | -7% |
| Employees | 1 | — |
Legal name
Dr. Acke AB
Org number
5590939889
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 december 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget har till föremål för sin verksamhet att bedriva konsultverksamhet inom sjukvård och friskvård och därmed förenlig verksamhet, direkt eller indirekt, äga och förvalta lös egendom och eget kaptial.
Address
Tegnérgatan 45
Email
vthessen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 91 | 230 | 145 | 297 | 151 |
| Staff expenses | — | — | −72 | −119 | −30 |
| EBITDA | 33 | 103 | −21 | 59 | 15 |
| Depreciation & amort. | −8 | −8 | −8 | −8 | −8 |
| EBIT | 25 | 95 | −29 | 51 | 6 |
| Net financials | −7 | −6 | −10 | −14 | −11 |
| Profit before tax | 19 | 89 | −39 | 37 | −4 |
| Tax | −4 | −18 | — | −0 | −2 |
| Net profit | 15 | 71 | −39 | 37 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 355 | 470 | 299 | 362 | 283 |
| Equity | 65 | 136 | 47 | 84 | 78 |
| Long-term debt | 252 | 200 | 200 | 200 | 200 |
| Short-term debt | 38 | 134 | 52 | 78 | 6 |
| Total debt | 290 | 334 | 252 | 278 | 206 |
EBITDA margin
9.7%
This company
15.8%
Market median
-39% vs market
20202024
Equity ratio
27.4%
This company
38.2%
Market median
-28% vs market
20202024
Return on equity
-7.7%
This company
18.4%
Market median
-142% vs market
20202024
Net profit margin
-3.9%
This company
8.1%
Market median
-148% vs market
20202024
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
20202024
Debt / equity
2.65×
This company
0.62×
Market median
-327% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Acke AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Victor Dracke-Thessén | Board of Directors | 0 companies |
| Josefine H T Dracke-Thessén | Deputy Board Member | 0 companies |